Call for Abstract

9th International Conference on Biomarkers, will be organized around the theme “Innovation and Implementation : Cancer Treatment”

Biomarkers Congress 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Biomarkers Congress 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1New strategies for discovery
  • Track 1-2Protein biomarker discovery
  • Track 1-3Mass spectrometry based biomarker discovery
  • Track 1-4Biomarkers for paediatric diseases
  • Track 1-5Clinical analysis of NGS samples
  • Track 2-1Biomarkers in Drug Safety
  • Track 2-2Biomarkers : PK/PD
  • Track 2-3Biomarkers : Efficacy
  • Track 3-1Omics Technologies in Biomarkers Discovery and Validation
  • Track 3-2Assessment of drug response
  • Track 3-3Latest diagnosis techniques
  • Track 3-4Application of tools
  • Track 3-5Advancements in analysis
  • Track 4-1Biomarkers & Surrogate Endpoints for Clinical Trials
  • Track 4-2Clinical biomarkers in oncology
  • Track 4-3Clinical biomarkers and pharmacogenomics
  • Track 4-4Clinical biomarkers in diagnostics
  • Track 5-1Biomarkers for lung and breast cancer
  • Track 5-2Biomarkers for blood cancer
  • Track 5-3Biomarkers for gastric cancer
  • Track 5-4Biomarkers for colorectal cancer
  • Track 5-5Biomarkers for adrenal cancer
  • Track 5-6Biomarkers for prostate cancer
  • Track 5-7Biomarkers for ovarian cancer
  • Track 5-8Cancer Metabolomics and Biomarkers
  • Track 6-1Biomarkers for Alzheimer’s
  • Track 6-2Biomarkers for Cardiovascular diseases
  • Track 6-3Biomarkers for Neurodegenerative diseases
  • Track 6-4Biomarkers for Diabetes
  • Track 6-5Biomarkers for Huntington diseases
  • Track 6-6Biomarkers for Behcet s disease
  • Track 6-7Biomarkers for other diseases
  • Track 7-1Technology to capture and distinguish
  • Track 7-2Patient administration
  • Track 7-3Targeted delivery
  • Track 7-4New Developments in Cell Free Biomarkers
  • Track 8-1Identifying and prioritizing biomarkers
  • Track 8-2Circulating biomarkers
  • Track 8-3Patient stratification using NGS data
  • Track 8-4Challenges and solutions for NGS labs
  • Track 9-1Genetic testing and Molecular Biomarkers
  • Track 9-2Biomarker testing for cancers
  • Track 9-3Biomarker testing for other diseases
  • Track 9-4Biomarker testing in diagnosis
  • Track 10-1Diagnosis and intervention
  • Track 10-2Big Data Analytics for Biomarkers Development
  • Track 10-3Cancer genomics
  • Track 10-4Challenges and probable solutions
  • Track 10-5Tumor biomarkers
  • Track 10-6Diagnostic and prognostic biomarkers
  • Track 11-1In vitro companion diagnostics devices
  • Track 11-2Clinical Utility of Diagnostic & Screening Biomarkers
  • Track 11-3Commercialization of companion diagnostics
  • Track 11-4Strategies for Rx-Dx partnerships
  • Track 12-1Biomarkers in translational medicine
  • Track 12-2Biomarker utility in clinical development
  • Track 12-3Safety assessment
  • Track 13-1Imaging Biomarkers
  • Track 13-2Clinical imaging and Biomarkers
  • Track 13-3Fluorescent biomarkers
  • Track 13-4Cancer screening
  • Track 13-5Screening for other diseases
  • Track 13-6New generation tools and technologies
  • Track 14-1Case reports on molecular biomarkers
  • Track 14-2Case reports on cancer biomarkers
  • Track 14-3Case reports on diagnostics
  • Track 14-4Case reports on drug discovery
  • Track 14-5Case reports on imaging